Gresham Technologies Share Discussion Threads

[schytalk] 25/7/2016 08:24

Not the greatest announcement but 'explains' the current share price performance which is now showing no growth in the last year.

I had already pointed out that recurring revenue growth was, in percentage terms, dropping back. However, the recurring revenue base continues to grow so a 47% increase could represent a decent number and long term I think we would all be very happy with this number.

It will be interesting to see where the cash has gone but I suspect part of it will be currency exchange exposure given that a considerable part of the Gresham cost base is not in GBP.

It does seem that Ian Manocha has yet to make a mark and I remain concerned as regards his low profile, at the moment results do not speak kindly for him. Having said that, the revenue growth is 'in line with management expectations' (although not ahead as we would all like to see), management remains confident for the full year and 'we enter the second half with strong momentum'.

So it seems that the second half is expected to be strong and the interim report should show us where the cash has gone (Cloud solution development?), so roll on August 24.

[thebullyboy] 25/7/2016 07:29

Cash is down from 4.7m to 3.9m. Not happy with this. You cannot rely on continued sales spending to grow revenue. You have to allow current sales teams to get reaults and not keep growing them. I am assuming that is where the money has gone. Unless they have a new blockbuster product they have been spending on.

[amt] 25/7/2016 07:24

The words in the trading statement dont match the numbers. Only mid 40s% growth in Claretti doesnt sound good to me. I was looking for at least 100% growth from such a small base. Last time it was 200% plus. The legacy business seems to be holding up better but I am not invested for that. They are still burning cash since December which is a worry. Perhaps my expectations are too high but the share price is expecting a lot too.

[qantas] 24/7/2016 07:28

hxxp://corporatecomplianceinsights.com/cost-of-compliance/


The Cost of Compliance
Passive Responses to Regulations Can Mean Big Fines


Agile systems such as the Clareti platform from Gresham can process data in multiple formats and automatically verify and validate the information to remove the risk of human error. The result is a fully transparent integrity architecture, which ensures compliance and removes internal risk.

[jadeticl3] 19/7/2016 12:31

More than a squeeze, I would have thought.

[qantas] 19/7/2016 09:06

Good to see shorters getting it so wrong...

[qantas] 18/7/2016 07:46

Tech gone today FYI .....


ARM Holdings' directors have agreed a £23.4bn takeover offer by Japan's Softbank, in what could be the first major move sparked by the post-Brexit collapse in the value of the pound. The board of the Cambridge-based chip designer, which is a major supplier of components for smartphones made by the likes of Apple and Samsung, said it unanimously recommended the 1,700p-per-share cash offer, which is a 43% premium to the 1,188.73p price at which trading closed on Friday.

[4-10] 14/7/2016 09:25

very droll wh1spa I note that he did not thank his manager or his mum

[wh1spa] 13/7/2016 22:44

bob hoskins

[qantas] 13/7/2016 22:43

Global business development director....

[jadeticl3] 13/7/2016 22:01

This interview of Bill Blythe is VERY UPBEAT. What role does he have in Gresham? Thanks Quantas

[qantas] 13/7/2016 18:48

FTF News Technology Innovation Awards 2016 Video Interview: Bill Blythe of Gresham Computing

[jadeticl3] 13/7/2016 12:08

Thanks B1ggles.

[jadeticl3] 12/7/2016 08:33

Quantas, how do I convert your items to links I can faultlessly dial up. Please.

[qantas] 12/7/2016 08:10

hxxp://www.ftfnews.com/video/gresham-computing-hits-its-disruptive-technology-stride?utm_content=bufferd5eb7&utm_medium=social&utm_source=twitter&utm_campaign=earned_buffer_Maureen

[amt] 12/7/2016 06:00

Good point about being in a closed period. If contracts were being delayed impacting results they will need to issue a profit warning asap so if things have taken a turn for the worse we won't have to wait long to find out.

[richjp] 11/7/2016 16:11

I don't think you can compare a company like GSK with a small cap like GHT. I think the currency effect is more of a bonus, not a reason to either buy or sell a share. It's the fundamentals that matter in the end.

The real concern for me about Brexit and the uncertainty surrounding banks is will there be any orders deferred for GHT? Order deferrals or cancellations are far more important to GHT at its current stage of development, than to a major corporation like GSK.

As we are presumably in a closed period even Kestrel will not be allowed to mop up any shares being sold and thus it will only take a few share sales to move the price down.

That is why I would like to see a trading update but if we do not get one in the next couple of days I suspect we will just have to wait for the results.

[jadeticl3] 11/7/2016 15:11

Good day for the index, poor day for GHT. The buzz appears to have left this company at this time. It may be that the"new CEO" does not wish to overstate the companies prospects, but is he allowing the investing public to conclude that there is nothing to be excited about.

Given a rise of 70 points in the index just now, a 3% fall in GHT on one sale looks odd.

As I said previously, cash received abroad today, when repatriated to Uk is worth more than it was a month ago, and this has been recognised in many companies. Why not GHT.

[amt] 09/7/2016 18:58

I think you are broadly correct with the US market becoming more important so in the long run a weak pound will boost profits. Of course it makes people living and working in the UK poorer. It's a good way of introducing austerity without people noticing. I suspect the fall in share price is it slavishly following the weakness in banks for no logical reason. Brexit and all its legal aspects could generate work for Gresham I would have thought.

[jadeticl3] 09/7/2016 16:56

I have a big stake in GSK. These shares have moved up significantly since the Brexit vote. The story is that much of GSK's revenue comes from abroad and when this is brought back into UK, with the GBP so low compared with dollar etc., it now translates to significantly higher numbers. This appears to be well accepted so share price has move from £12-60 )ish) to £16-50 (ish) in this short space of time, and analysts are forecasting it to go higher.

I ask myself, is not the same true of GHT? Does this company not also earn much of its revenues abroad? Is what is true of GSK also true of GHT? So why has the share price of GHT not moved upwards?

Can someone see what is different between these 2 companies such that one has moved up rapidly and the other not at all? What am I not seeing?

[qantas] 04/7/2016 18:52

Regulators use Silicon Valley’s AI to catch rogue traders

[thebullyboy] 04/7/2016 15:19

I thought we were still in June!

[richjp] 04/7/2016 13:30

Half yearly results have to be announced within two months of the end of the period in question, so the end of August would be the very latest, although there should be no reason for them to wait that long.